Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

President Trump's decision to impose a US$100,000 annual fee on new H-1B visa applicants represents more than immigration ...

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced that the National Medical Products Administration ...

Vyvgart and robust R&D, balanced by risks and diversification potential. Read here for more analysis of ARGX stock.

The Community Opportunity Education Campus is a new public school located in Colorado Springs and Aurora. The school is ...

Opinion - Real autonomy will come when states build prosperity through competition, innovation, and resilience.

Plurilateralism refers to cooperation among a “subset of countries”, usually within a broader multilateral framework, ...

Reaching Full Retirement Age in 2025 without 40 credits does not trigger Social Security retirement benefits; other paths and ...

The Red Sea’s congestion — exacerbated by Houthi attacks rerouting ships — heightens this risk. Historical examples include ...

Xenotransplantation, leveraging genetic engineering and CRISPR, offers a promising solution to the organ shortage crisis ...

The language of power matters. Political actors do not merely deploy words to inform; they use them to manage perceptions, ...